All companies
Reserve Investment 
Neuralink
Series D
Neurotechnology
Valuation
$9.0B
Funding Stage
Series D
Expected IPO
~2029
Minimum
$5,000
About Neuralink
Neuralink builds implantable brain-computer interfaces that let people control devices with thought, with early human trials targeting paralysis, vision, and neurological conditions.
Figures shown are indicative and do not constitute investment advice.
Related opportunities
SpaceX
Aerospace & Launch
Reusable rockets making humanity multiplanetary.
Pre-IPO
IPO ~2027
Valuation
$350.0B
Minimum
$1,000
Starlink
Satellite Internet
High-speed internet beamed from low-Earth orbit.
Pre-IPO
IPO ~2027
Valuation
$137.0B
Minimum
$1,000
xAI
Artificial Intelligence
Frontier AI building Grok and a maximally curious AGI.
Series C
IPO ~2028
Valuation
$50.0B
Minimum
$1,000